Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Timothy Edwin Wilens, M.D.

TitleAssociate Professor of Psychiatry
InstitutionMassachusetts General Hospital
DepartmentPsychiatry
AddressMassachusetts General Hospital
Yawkey 6900
55 Fruit St
Boston MA 02114
Phone617/724-5600
Fax617/724-3742

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Wilens TE, Rosenbaum JF. Transitional aged youth: a new frontier in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry. 2013 Sep; 52(9):887-90.
    View in: PubMed
  2. Yule AM, Wilens TE, Martelon MK, Simon A, Biederman J. Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study. Am J Addict. 2013 Sep; 22(5):460-5.
    View in: PubMed
  3. Stevens JR, Wilens TE, Stern TA. Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges. Prim Care Companion CNS Disord. 2013; 15(2).
    View in: PubMed
  4. Wilens TE, Martelon M, Anderson JP, Shelley-Abrahamson R, Biederman J. Difficulties in emotional regulation and substance use disorders: A controlled family study of bipolar adolescents. Drug Alcohol Depend. 2013 Sep 1; 132(1-2):114-21.
    View in: PubMed
  5. Herring WJ, Wilens TE, Adler LA, Baranak C, Liu K, Snavely DB, Lines CR, Michelson D. Randomized controlled study of the histamine H3 inverse agonist MK-0249 in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2012 Jul; 73(7):e891-8.
    View in: PubMed
  6. Martelon M, Wilens TE, Anderson JP, Morrison NR, Wozniak J. Are obstetrical, perinatal, and infantile difficulties associated with pediatric bipolar disorder? Bipolar Disord. 2012 Aug; 14(5):507-14.
    View in: PubMed
  7. Hammerness P, Zusman R, Systrom D, Surman C, Baggish A, Schillinger M, Shelley-Abrahamson R, Wilens TE. A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry. 2013 May; 14(4):299-306.
    View in: PubMed
  8. Adler LA, Wilens T, Zhang S, Dittmann RW, D'Souza DN, Schuh L, Durell TM. Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis. Clin Ther. 2012 Feb; 34(2):363-73.
    View in: PubMed
  9. Wilens TE, Bukstein O, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha S. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan; 51(1):74-85.e2.
    View in: PubMed
  10. Wilens TE, Adler LA, Tanaka Y, Xiao F, D'Souza DN, Gutkin SW, Upadhyaya HP. Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin. 2011 Dec; 27(12):2309-20.
    View in: PubMed
  11. Wilens TE, Morrison NR, Prince J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2011 Oct; 11(10):1443-65.
    View in: PubMed
  12. Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations. J Am Acad Child Adolesc Psychiatry. 2011 Oct; 50(10):978-90.
    View in: PubMed
  13. Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens TE, Smalley S, McCracken J, Biederman J, Faraone SV. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2011 Aug; 50(8):807-17.e8.
    View in: PubMed
  14. Wilens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry. 2011 Jul; 24(4):280-5.
    View in: PubMed
  15. Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011 Jun; 50(6):543-53.
    View in: PubMed
  16. Biederman J, Petty CR, Wozniak J, Wilens TE, Fried R, Doyle A, Henin A, Bateman C, Evans M, Faraone SV. Impact of executive function deficits in youth with bipolar I disorder: a controlled study. Psychiatry Res. 2011 Mar 30; 186(1):58-64.
    View in: PubMed
  17. Hua LL, Wilens TE, Martelon M, Wong P, Wozniak J, Biederman J. Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features. J Clin Psychiatry. 2011 Mar; 72(3):397-405.
    View in: PubMed
  18. Wilens TE, Martelon M, Fried R, Petty C, Bateman C, Biederman J. Do executive function deficits predict later substance use disorders among adolescents and young adults? J Am Acad Child Adolesc Psychiatry. 2011 Feb; 50(2):141-9.
    View in: PubMed
  19. Wilens TE. A sobering fact: ADHD leads to substance abuse. J Am Acad Child Adolesc Psychiatry. 2011 Jan; 50(1):6-8.
    View in: PubMed
  20. Wilens TE, Gault LM, Childress A, Kratochvil CJ, Bensman L, Hall CM, Olson E, Robieson WZ, Garimella TS, Abi-Saab WM, Apostol G, Saltarelli MD. Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry. 2011 Jan; 50(1):73-84.e1.
    View in: PubMed
  21. Lorberg B, Wilens TE, Martelon M, Wong P, Parcell T. Reasons for substance use among adolescents with bipolar disorder. Am J Addict. 2010 Nov-Dec; 19(6):474-80.
    View in: PubMed
  22. Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010 Sep; 122(5):97-109.
    View in: PubMed
  23. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, Biederman J, Byrne D, Dechairo B, Guiney A, McCracken J, McGough J, Nelson SF, Reiersen AM, Wilens TE, Wozniak J, Neale BM, Faraone SV. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):898-905.e3.
    View in: PubMed
  24. Wilens TE, Hammerness P, Martelon M, Brodziak K, Utzinger L, Wong P. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 May; 71(5):548-56.
    View in: PubMed
  25. Stevens JR, George RA, Fusillo S, Stern TA, Wilens TE. Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation. J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):49-54.
    View in: PubMed
  26. Biederman J, Petty CR, Monuteaux MC, Fried R, Byrne D, Mirto T, Spencer T, Wilens TE, Faraone SV. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry. 2010 Apr; 167(4):409-17.
    View in: PubMed
  27. Durell T, Adler L, Wilens T, Paczkowski M, Schuh K. Atomoxetine treatment for ADHD: younger adults compared with older adults. J Atten Disord. 2010 Jan; 13(4):401-6.
    View in: PubMed
  28. Newcorn JH, Sutton VK, Zhang S, Wilens T, Kratochvil C, Emslie GJ, D'souza DN, Schuh LM, Allen AJ. Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009 Dec; 48(12):1165-72.
    View in: PubMed
  29. Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry. 2009 Nov; 70(11):1557-62.
    View in: PubMed
  30. Hammerness P, Georgiopoulos A, Doyle RL, Utzinger L, Schillinger M, Martelon M, Brodziak K, Biederman J, Wilens TE. An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):493-9.
    View in: PubMed
  31. Potter MP, Liu HY, Monuteaux MC, Henderson CS, Wozniak J, Wilens TE, Biederman J. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):529-38.
    View in: PubMed
  32. Wilens TE, Hammerness P, Utzinger L, Schillinger M, Georgiopoulous A, Doyle RL, Martelon M, Brodziak K. An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):485-92.
    View in: PubMed
  33. Wilens TE. Combined pharmacotherapy in pediatric psychopharmacology: friend or foe? J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):483-4.
    View in: PubMed
  34. Adler L, Wilens T, Zhang S, Durell T, Walker D, Schuh L, Jin L, Feldman P, Trzepacz P. Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict. 2009 Sep-Oct; 18(5):393-401.
    View in: PubMed
  35. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009 Jul; 124(1):71-8.
    View in: PubMed
  36. Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):519-32.
    View in: PubMed
  37. Biederman J, Petty CR, Wilens TE, Spencer T, Henin A, Faraone SV, Mick E, Monuteaux MC, Kenealy D, Mirto T, Wozniak J. Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. Bipolar Disord. 2009 May; 11(3):298-306.
    View in: PubMed
  38. Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr. 2009 Jul; 155(1):84-9, 89.e1.
    View in: PubMed
  39. Joshi G, Wilens T. Comorbidity in pediatric bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2009 Apr; 18(2):291-319, vii-viii.
    View in: PubMed
  40. Buitelaar JK, Wilens TE, Zhang S, Ning Y, Feldman PD. Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry. 2009 Mar; 50(3):335-42.
    View in: PubMed
  41. Steinbuchel PH, Wilens TE, Adamson JJ, Sgambati S. Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder. Bipolar Disord. 2009 Mar; 11(2):198-204.
    View in: PubMed
  42. Wilens TE, Martelon M, Kruesi MJ, Parcell T, Westerberg D, Schillinger M, Gignac M, Biederman J. Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study. J Clin Psychiatry. 2009 Feb; 70(2):259-65.
    View in: PubMed
  43. Mick E, Wozniak J, Wilens TE, Biederman J, Faraone SV. Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children. BMC Psychiatry. 2009; 9:2.
    View in: PubMed
  44. Redden L, DelBello M, Wagner KD, Wilens TE, Malhotra S, Wozniak P, Vigna NV, Greco N, Kovacs X, Abi-Saab W, Saltarelli M. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol. 2009 Feb; 19(1):83-9.
    View in: PubMed
  45. Doyle AE, Wozniak J, Wilens TE, Henin A, Seidman LJ, Petty C, Fried R, Gross LM, Faraone SV, Biederman J. Neurocognitive impairment in unaffected siblings of youth with bipolar disorder. Psychol Med. 2009 Aug; 39(8):1253-63.
    View in: PubMed
  46. Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Parcell T, Westerberg D, Biederman J. Concordance between cigarette smoking and the modified Fagerström Tolerance Questionnaire in controlled studies of ADHD. Am J Addict. 2008 Nov-Dec; 17(6):491-6.
    View in: PubMed
  47. Mick E, Kim JW, Biederman J, Wozniak J, Wilens T, Spencer T, Smoller JW, Faraone SV. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5; 147B(7):1182-5.
    View in: PubMed
  48. Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008 Oct; 162(10):916-21.
    View in: PubMed
  49. Monuteaux MC, Faraone SV, Hammerness P, Wilens TE, Fraire M, Biederman J. The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families. Nicotine Tob Res. 2008 Oct; 10(10):1549-58.
    View in: PubMed
  50. Wilens TE, Klint T, Adler L, West S, Wesnes K, Graff O, Mikkelsen B. A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Behav Brain Funct. 2008; 4:24.
    View in: PubMed
  51. Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, Biederman J. Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr. 2008 Sep; 153(3):414-9.
    View in: PubMed
  52. Wilens TE. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2008 Jun; 28(3 Suppl 2):S46-53.
    View in: PubMed
  53. Wilens TE, Boellner SW, López FA, Turnbow JM, Wigal SB, Childress AC, Abikoff HB, Manos MJ. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Jun; 47(6):700-8.
    View in: PubMed
  54. Wilens TE. Pharmacotherapy of ADHD in adults. CNS Spectr. 2008 May; 13(5 Suppl 8):11-3.
    View in: PubMed
  55. Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 1; 96(1-2):145-54.
    View in: PubMed
  56. Wilens TE, Biederman J, Adamson JJ, Henin A, Sgambati S, Gignac M, Sawtelle R, Santry A, Monuteaux MC. Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. Drug Alcohol Depend. 2008 Jun 1; 95(3):188-98.
    View in: PubMed
  57. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008 May; 165(5):597-603.
    View in: PubMed
  58. Hammerness PG, Wilens TE, Berul CI, Elkort MS. Supraventricular tachycardia in an adolescent with attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):219-20.
    View in: PubMed
  59. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008 Jan; 47(1):21-31.
    View in: PubMed
  60. Biederman J, Petty CR, Wilens TE, Fraire MG, Purcell CA, Mick E, Monuteaux MC, Faraone SV. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2008 Jan; 165(1):107-15.
    View in: PubMed
  61. Wilens TE, Fusillo S. When ADHD and substance use disorders intersect: relationship and treatment implications. Curr Psychiatry Rep. 2007 Oct; 9(5):408-14.
    View in: PubMed
  62. Faraone SV, Adamson JJ, Wilens TE, Monuteaux MC, Biederman J. Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders. Drug Alcohol Depend. 2008 Jan 1; 92(1-3):100-7.
    View in: PubMed
  63. Monuteaux MC, Wilens TE, Biederman J. Does social class predict substance problems in young adults with ADHD? Am J Addict. 2007 Sep-Oct; 16(5):403-9.
    View in: PubMed
  64. Wilens TE, Upadhyaya HP. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry. 2007 Aug; 68(8):e20.
    View in: PubMed
  65. Wilens TE, Decker MW. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol. 2007 Oct 15; 74(8):1212-23.
    View in: PubMed
  66. Wigal SB, Wilens TE, Wolraich M, Lerner M. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Pediatrics. 2007 Jul; 120(1):e120-8.
    View in: PubMed
  67. Wilens TE, Biederman J, Adamson J, Monuteaux M, Henin A, Sgambati S, Santry A, Faraone SV. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder. Biol Psychiatry. 2007 Jul 15; 62(2):129-34.
    View in: PubMed
  68. Wilens TE. ADHD: prevalence, diagnosis, and issues of comorbidity. CNS Spectr. 2007 Apr; 12(4 Suppl 6):1-5.
    View in: PubMed
  69. Faraone SV, Biederman J, Wilens TE, Adamson J. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med. 2007 Dec; 37(12):1743-52.
    View in: PubMed
  70. Wilens TE, Adamson J, Sgambati S, Whitley J, Santry A, Monuteaux MC, Biederman J. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict. 2007; 16 Suppl 1:14-21; quiz 22-3.
    View in: PubMed
  71. Faraone SV, Wilens TE, Petty C, Antshel K, Spencer T, Biederman J. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict. 2007; 16 Suppl 1:24-32; quiz 33-4.
    View in: PubMed
  72. Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry. 2007; 68 Suppl 11:15-22.
    View in: PubMed
  73. Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry. 2007; 68 Suppl 11:4-8.
    View in: PubMed
  74. Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2006 Dec; 163(12):2059-63.
    View in: PubMed
  75. Faraone SV, Adamson JJ, Wilens TE, Monuteaux MC, Biederman J. Deriving phenotypes for molecular genetic studies of substance use disorders: a family study approach. Drug Alcohol Depend. 2007 May 11; 88(2-3):244-50.
    View in: PubMed
  76. Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1147-50.
    View in: PubMed
  77. Adler LA, Reingold LS, Morrill MS, Wilens TE. Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep. 2006 Oct; 8(5):409-15.
    View in: PubMed
  78. Polzer J, Bangs ME, Zhang S, Dellva MA, Tauscher-Wisniewski S, Acharya N, Watson SB, Allen AJ, Wilens TE. Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biol Psychiatry. 2007 Mar 1; 61(5):713-9.
    View in: PubMed
  79. Kratochvil CJ, Wilens TE, Upadhyaya H. Pharmacological management of a youth with ADHD, marijuana use, and mood symptoms. J Am Acad Child Adolesc Psychiatry. 2006 Sep; 45(9):1138-41.
    View in: PubMed
  80. Wilens TE, Prince JB, Spencer TJ, Biederman J. Stimulants and sudden death: what is a physician to do? Pediatrics. 2006 Sep; 118(3):1215-9.
    View in: PubMed
  81. Kratochvil CJ, Kazura A, Deas D, Martin CA, Dosh T, Wilens TE. Pharmacological management of a teen with significant alcohol use and depression. J Am Acad Child Adolesc Psychiatry. 2006 Aug; 45(8):1011-5.
    View in: PubMed
  82. Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006 Aug; 11(8):625-39.
    View in: PubMed
  83. Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD, Gelowitz DL. Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Aug; 45(8):919-27.
    View in: PubMed
  84. Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006 Jul; 163(7):1179-86.
    View in: PubMed
  85. Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr. 2006 Jul; 149(1):112-9.
    View in: PubMed
  86. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):351-6.
    View in: PubMed
  87. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Klein KL, Price JE, Faraone SV. Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry. 2006 Nov 15; 60(10):1098-105.
    View in: PubMed
  88. Lasky-Su J, Biederman J, Doyle AE, Wilens T, Monuteaux M, Smoller JW, Faraone S. Family based association analysis of statistically derived quantitative traits for drug use in ADHD and the dopamine transporter gene. Addict Behav. 2006 Jun; 31(6):1088-99.
    View in: PubMed
  89. Wilens TE, Zusman RM, Hammerness PG, Podolski A, Whitley J, Spencer TJ, Gignac M, Biederman J. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension. J Clin Psychiatry. 2006 May; 67(5):696-702.
    View in: PubMed
  90. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006 Apr; 45(4):408-14.
    View in: PubMed
  91. Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry. 2006 Jun 1; 59(11):1065-70.
    View in: PubMed
  92. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006 Feb; 36(2):167-79.
    View in: PubMed
  93. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006 Feb; 28(2):266-79.
    View in: PubMed
  94. Wilens TE, Kratochvil C, Newcorn JH, Gao H. Do children and adolescents with ADHD respond differently to atomoxetine? J Am Acad Child Adolesc Psychiatry. 2006 Feb; 45(2):149-57.
    View in: PubMed
  95. Doyle RL, Frazier J, Spencer TJ, Geller D, Biederman J, Wilens T. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series. J Atten Disord. 2006 Feb; 9(3):543-9.
    View in: PubMed
  96. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006 Jan; 160(1):82-90.
    View in: PubMed
  97. Biederman J, Arnsten AF, Faraone SV, Doyle AE, Spencer TJ, Wilens TE, Weiss MD, Safren SA, Culpepper L. New developments in the treatment of ADHD. J Clin Psychiatry. 2006 Jan; 67(1):148-59.
    View in: PubMed
  98. Wilens TE. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006; 67 Suppl 8:32-8.
    View in: PubMed
  99. Wilens TE, Waxmonsky J, Scott M, Swezey A, Kwon A, Spencer TJ, Biederman J. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 Dec; 15(6):947-55.
    View in: PubMed
  100. Weisler RH, Biederman J, Spencer TJ, Wilens TE. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005 Dec; 10(12 Suppl 20):35-43.
    View in: PubMed
  101. Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005 Dec; 10(12 Suppl 20):16-25.
    View in: PubMed
  102. Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1015-23.
    View in: PubMed
  103. Wilens TE, Spencer TJ, Biederman J. Short- and long-term cardiovascular effects of mixed amphetamine salts extended-release in adolescents with ADHD. CNS Spectr. 2005 Oct; 10(10 Suppl 15):22-30.
    View in: PubMed
  104. Waxmonsky JG, Wilens TE. Pharmacotherapy of adolescent substance use disorders: a review of the literature. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):810-25.
    View in: PubMed
  105. Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):787-98.
    View in: PubMed
  106. Gignac M, Wilens TE, Biederman J, Kwon A, Mick E, Swezey A. Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you? J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):742-50.
    View in: PubMed
  107. Solhkhah R, Wilens TE, Daly J, Prince JB, Van Patten SL, Biederman J. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):777-86.
    View in: PubMed
  108. Spencer TJ, Biederman J, Wilens TE. Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended release in adolescents with ADHD. CNS Spectr. 2005 Oct; 10(10 Suppl 15):14-21.
    View in: PubMed
  109. Wilens TE. The need to study substance use disorders. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):720-2.
    View in: PubMed
  110. Doyle AE, Wilens TE, Kwon A, Seidman LJ, Faraone SV, Fried R, Swezey A, Snyder L, Biederman J. Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry. 2005 Oct 1; 58(7):540-8.
    View in: PubMed
  111. Wilens TE, Biederman J. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol. 2006 Jul; 20(4):580-8.
    View in: PubMed
  112. Biederman J, Monuteaux MC, Mick E, Wilens TE, Fontanella JA, Poetzl KM, Kirk T, Masse J, Faraone SV. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry. 2006 Feb 1; 59(3):258-64.
    View in: PubMed
  113. Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr. 2005 Sep; 147(3):348-54.
    View in: PubMed
  114. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005 Jul; 43(7):831-42.
    View in: PubMed
  115. Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV, Biederman J. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict. 2005 Jul-Sep; 14(4):319-27.
    View in: PubMed
  116. Wolraich ML, Wibbelsman CJ, Brown TE, Evans SW, Gotlieb EM, Knight JR, Ross EC, Shubiner HH, Wender EH, Wilens T. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005 Jun; 115(6):1734-46.
    View in: PubMed
  117. Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005 Apr 1; 57(7):793-801.
    View in: PubMed
  118. Wilens TE, Hahesy AL, Biederman J, Bredin E, Tanguay S, Kwon A, Faraone SV. Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Am J Addict. 2005 Mar-Apr; 14(2):179-87.
    View in: PubMed
  119. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Mar 1; 57(5):456-63.
    View in: PubMed
  120. Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005 Feb; 66(2):253-9.
    View in: PubMed
  121. Wilens T, Biederman J, Spencer T. Recent Trends in Pediatric Psychopharmacology. In: Koocher GP, Norcross JC, Hill S, editors. Psychologists Desk Reference. 2005; 466-475.
  122. Wilens TE, Biederman J, Kwon A, Ditterline J, Forkner P, Moore H, Swezey A, Snyder L, Henin A, Wozniak J, Faraone SV. Risk of substance use disorders in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1380-6.
    View in: PubMed
  123. Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, Ferrero F, Morgan CL, Faraone SV. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol. 2004 Oct; 72(5):757-66.
    View in: PubMed
  124. Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry. 2004 Oct; 65(10):1301-13.
    View in: PubMed
  125. Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. JAMA. 2004 Aug 4; 292(5):619-23.
    View in: PubMed
  126. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am. 2004 Jun; 27(2):283-301.
    View in: PubMed
  127. Spencer T, Biederman J, Wilens T. Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004 Jun; 27(2):373-83.
    View in: PubMed
  128. Spencer T, Biederman J, Wilens T. Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004 Jun; 27(2):361-72.
    View in: PubMed
  129. Wilens TE, Biederman J, Lerner M. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. J Clin Psychopharmacol. 2004 Feb; 24(1):36-41.
    View in: PubMed
  130. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004 Mar; 7(1):77-97.
    View in: PubMed
  131. Wilens T. Substance abuse with ADHD: Nature of the relationship, subtypes at risk, and treatment implications. In: Spencer T, editors. Psychiatric Clinics of North America. 2004; (27):283-302.
  132. Wilens TE. Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry. 2004; 65 Suppl 3:38-45.
    View in: PubMed
  133. Spencer T, Biederman J, Wilens T. Stimulent Treatment in Adult ADHD. In: Spencer T, editors. Psychiatric Clinics of North America. 2004; (27):361-372.
  134. Wilens T, Biederman J, Spencer T. The patient with Attention deficit hyperactivity disorder. In: Stern T, Herman J, Slavin P, editors. MGH Guide to Primary Care Psychiatry. 2004; 287-300.
  135. T.E. Wilens. Straight Talk About Psychiatric Medication for Kids. 2004.
  136. Spencer T, Biederman J, Wilens T. Nonstimulant Treatment in Adult ADHD. In: Spencer T, editors. Psychiatric Clinics of North America. 2004; (27):373-384.
  137. Prince J, Wilens T, Biederman J, Spencer T. Psychopharmacology for children and adolescents. In: Stern T, Fricchione G, Cassem N, Jellinek M. Rosenbaum J. MGH: Handbook of the General Hospital Psychiatry. 2004; 411-446.
  138. Gonzalez-Heydrich J, Raches D, Wilens TE, Leichtner A, Mezzacappa E. Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination. J Am Acad Child Adolesc Psychiatry. 2003 Oct; 42(10):1227-33.
    View in: PubMed
  139. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol. 2003 Sep; 6(3):293-300.
    View in: PubMed
  140. Wilens TE. Does the medicating ADHD increase or decrease the risk for later substance abuse? Rev Bras Psiquiatr. 2003 Sep; 25(3):127-8.
    View in: PubMed
  141. Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003 Jul 1; 54(1):9-16.
    View in: PubMed
  142. Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry. 2003 Jul 1; 54(1):1-8.
    View in: PubMed
  143. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33.
    View in: PubMed
  144. Witcher J, Long A, Sauer J, Heiligenstein J, Wilens T, Biederman J, Spencer T. Atomoxetine pahracokinetics in children with ADHD. J Child Adolesc Psychopharm. 2003; 13.
  145. Witcher JW, Long A, Smith B, Sauer JM, Heilgenstein J, Wilens T, Spencer T, Biederman J. Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2003; 13(1):53-63.
    View in: PubMed
  146. Wilens TE. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs. 2003; 63(22):2395-411.
    View in: PubMed
  147. Biederman J, Spencer T, Wilens T. Chapter 50 Psychopharmacology. In: weiner J, Dulcan M, editors. Textbook of Child and Adolescent Psychiatry. 2003; 931-974.
  148. Wilens T. A review of pharmacotherapy for adults with ADHD. Drugs. 2003; 63:2395-2411.
  149. Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry. 2003; 64 Suppl 11:9-13.
    View in: PubMed
  150. Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, Spencer TJ. A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol. 2003; 13(2):143-52.
    View in: PubMed
  151. Biederman J, Mick E, Faraone S, Spencer T, Wilens T, Wozniak J. Current concepts in the validity, diagnosis, and treatment of pediatric bipolar disorder. Internation Journal of Neuropsychopharmacology. 2003; 6:293-300.
  152. Spencer T, Biederman J, Wilens T, Greene R. Attention-deficit/hyperactivity disorder. In: Martin A, Scahhil L, Charney D, Leckman J, editors. Pediatric Psychopharmacology . 2003; 447-455.
  153. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003 Jan; 111(1):179-85.
    View in: PubMed
  154. Wilens TE, Biederman J, Forkner P, Ditterline J, Morris M, Moore H, Galdo M, Spencer TJ, Wozniak J. Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. J Child Adolesc Psychopharmacol. 2003; 13(4):495-505.
    View in: PubMed
  155. Wilens T, Biederman J, Kwon A, Chase R, Greenberg L, Spencer T. A systematic chart review of the nature and charaterictics of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adoles Psychopharm. 2003; 13:143-152.
  156. Wilens TE, Cohen L, Biederman J, Abrams A, Neft D, Faird N, Sinha V. Fluoxetine pharmacokinetics in pediatric patients. J Clin Psychopharmacol. 2002 Dec; 22(6):568-75.
    View in: PubMed
  157. Hahesy AL, Wilens TE, Biederman J, Van Patten SL, Spencer T. Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency. Psychiatry Res. 2002 Apr 15; 109(3):245-53.
    View in: PubMed
  158. Wilens TE, Biederman J, Brown S, Tanguay S, Monuteaux MC, Blake C, Spencer TJ. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):262-8.
    View in: PubMed
  159. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord. 2002 Mar; 5(4):189-202.
    View in: PubMed
  160. Wilens TE, Biederman J, Brown S, Monuteaux M, Prince J, Spencer TJ. Patterns of psychopathology and dysfunction in clinically referred preschoolers. J Dev Behav Pediatr. 2002 Feb; 23(1 Suppl):S31-6.
    View in: PubMed
  161. Prince J, Wilens T. Pharmacotherapy of ADHD in Women. In: Quinn P, Nadeau K, editors. Understanding Women with ADHD. 2002; 144-182.
  162. Wilens T, Spencer T, Biederman J, Prince J. Pharmacotherapy of ADHD in adults: A review of the literature. J Att Disorders. 2002; 5:189-202.
  163. Wilens T. ADHD and the substance use disorders:The Nature of the relationship, subtypes at risk, and treatment issues. In: Jensen PS, Cooper JR, editors. Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. 2002; (19):1-12.
  164. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002 Jan; 159(1):36-42.
    View in: PubMed
  165. Waxmonsky J, Wilens T. Pharmacotherapy of Adolescent Substance Abuse. In: Martin A, Scahhill L, Charney D, Leckman J, editors. Pediatric Psychopharmacology. 2002; 605-616.
  166. Wilens T, Biederman J, Spencer T. Attention-deficit/hyperactivity disorder. In: Caskey CT, editors. Annual review of Medicine. 2002; (53):113-151.
  167. Prince J, Wilens T.E. Medical Issues for Women with ADH/HD: Pharmacologic Treatment. In: Nadeau K, Quinn P, editors. Gender Issues and AD/HD:Research, Diagnosis, and Treatment. 2002; 46-69.
  168. Wilens TE, Biederman J, Bredin E, Hahesy AL, Abrantes A, Neft D, Millstein R, Spencer TJ. A family study of the high-risk children of opioid- and alcohol-dependent parents. Am J Addict. 2002; 11(1):41-51.
    View in: PubMed
  169. Wilens T, Spencer T, Biederman J. Attention-deficit/hyperactivity disorder. In: finberg L, Kleinman R, editors. Saunders Manual of Pediatric Practice. 2002; 212-215.
  170. Wilens T, Biederman J, Bredin E, Hahesy A, Abrantes A, Neft D, Millstein R, Spencer T. Psychopathology in the offspring of opioid and alcohol dependent parents. American Journal on Addictions. 2002; 11:41-51.
  171. Prince J, Wilens T. Pharmacotherapy of Adults with ADHD. In: Goldstein S, Ellison A, editors. Clinician's Guide to ADHD in Adults . 2002; 165-182.
  172. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002; 63 Suppl 12:3-9.
    View in: PubMed
  173. Wilens TE, Biederman J, Spencer TJ. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med. 2002; 53:113-31.
    View in: PubMed
  174. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002; 63 Suppl 12:16-22.
    View in: PubMed
  175. Faraone SV, Biederman J, Mick E, Doyle AE, Wilens T, Spencer T, Frazier E, Mullen K. A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001 Oct 15; 50(8):586-92.
    View in: PubMed
  176. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct; 108(4):883-92.
    View in: PubMed
  177. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, Doyle R, Parekh A, Kagan J, Bearman SK. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001 Aug; 58(8):775-82.
    View in: PubMed
  178. Spencer TJ, Biederman J, Wozniak J, Faraone SV, Wilens TE, Mick E. Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biol Psychiatry. 2001 Jun 15; 49(12):1062-70.
    View in: PubMed
  179. Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D, Kagan J, Bearman SK, Wilens T. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr; 158(4):611-7.
    View in: PubMed
  180. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001 Feb; 158(2):282-8.
    View in: PubMed
  181. Biederman J, Spencer T, Wilens T, Green R. ADHD. In: Gabbard G. Treatments of Psychiatric disorders. 2001; 145-176.
  182. Biederman J, Spencer T, Wilens T. Approach to the patient with Attention-deficit/hyperactivity disorder. Practical Guide to Psychiatry. 2001.
  183. Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone SV, Rea J, Witcher J, Zervas S. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001; 11(3):251-65.
    View in: PubMed
  184. Wilens T. Pharmacologic management of ADHD. TEN. 2001; 3:54-59.
  185. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Adv Neurol. 2001; 85:57-77.
    View in: PubMed
  186. Wilens T. Attention-deficit /hyperactivity disorder. In: Rakel R, editors. Conn's Current Therapy. 2001; 52.
  187. Faraone SV, Biederman J, Spencer TJ, Wilens TE. The drug-placebo response curve: a new method for assessing drug effects in clinical trials. J Clin Psychopharmacol. 2000 Dec; 20(6):673-9.
    View in: PubMed
  188. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry. 2000 Sep 15; 48(6):458-66.
    View in: PubMed
  189. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000 Jul 1; 48(1):9-20.
    View in: PubMed
  190. Faraone SV, Biederman J, Mick E, Williamson S, Wilens T, Spencer T, Weber W, Jetton J, Kraus I, Pert J, Zallen B. Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry. 2000 Jul; 157(7):1077-83.
    View in: PubMed
  191. Wilens TE, Spencer TJ. The stimulants revisited. Child Adolesc Psychiatr Clin N Am. 2000 Jul; 9(3):573-603, viii.
    View in: PubMed
  192. Wilens TE, Biederman J, Wong J, Spencer TJ, Prince JB. Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series. J Child Adolesc Psychopharmacol. 2000; 10(3):217-22.
    View in: PubMed
  193. Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2000; 10(3):193-204.
    View in: PubMed
  194. Wilens TE, Biederman J, Milberger S, Hahesy AL, Goldman S, Wozniak J, Spencer TJ. Is bipolar disorder a risk for cigarette smoking in ADHD youth? Am J Addict. 2000; 9(3):187-95.
    View in: PubMed
  195. Spencer T, Biederman J, Wozniak J, Wilens T. Attention deficit hyperactivity disorder and affective disorders in childhood: Continuum, comorbidit or confusion. Current Opinion in Psychiatry. 2000; 13.
  196. Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol. 2000; 10(3):205-16.
    View in: PubMed
  197. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol. 2000; 10(3):185-92.
    View in: PubMed
  198. Wilens T, Spencer T, Biederman J. Psychopharmacology of ADHD. In: Brown T, editors. Attention Deficit Disorder and Comorbidities in Children, Adolescents, and Adults. 2000; 509-536.
  199. Spencer T, Biederman J, Wozniak J, Wilens T. . Attention deficit hyperactivity disorder and affective disorders in childhood: continum, comorbidity, or confusion. Current Opinion in Psychiatry. 2000; 13.
  200. Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000 Jan; 9(1):77-97.
    View in: PubMed
  201. McDermott SP, Wilens T. Cognitive therapy for adults with ADHD. In: Brown T editors. Attention Deficit Disorder and Comorbidities in Children, Adolescents and Adults. 2000; 569-606.
  202. Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder:Child and Adolescent. In: Psychiatric Clinics of North America of Psychopharmacology. 2000; 9:77-91.
  203. Swanson J, Greenhill L, Pelham W, Wilens T, Wolraich M, Abikoff H, Atkins M, August G, Biederman J, Bukstein O, Conners C, Hoffman M, Lerner M, Mcburnett K, Palumbo D, Stein M, Wigal S. Initiation of Concerta (OROS methylphenidate) qd in children with attention-deficit hyperactivity disorder. J Clin Research. 2000; 3:59-76.
  204. Wilens T, Spencer T, Biederman J. ADHD and substance abuse. In: Brown T, editors. Attention Deficit Disorder and Comorbitites in Children, Adolescents, and Adults. 2000; 319-340.
  205. Spencer T, Wilens T, Biederman J, Wozniak J, Crawford M. ADHD with mood disorders. In: Brown T, editors. Attention Deficit Disorder and Comorbiditites in Children, Adolescents, and Adults. 2000; 79-124.
  206. Prince J, Wilens T. Diagnosis and treatment of adults with ADHD. In: Accardo P, Blondis T, Whitman B, Stein M Attention Deficits and Hyperactivity in Children and Adolescents. 2000; 665-684.
  207. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1999 Dec; 156(12):1931-7.
    View in: PubMed
  208. Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am. 1999 Oct; 46(5):915-27, vii.
    View in: PubMed
  209. Greene RW, Biederman J, Faraone SV, Wilens TE, Mick E, Blier HK. Further validation of social impairment as a predictor of substance use disorders: findings from a sample of siblings of boys with and without ADHD. J Clin Child Psychol. 1999 Sep; 28(3):349-54.
    View in: PubMed
  210. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Sep; 56(9):842-7.
    View in: PubMed
  211. Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, Kim GS, Shapiro S. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 1999 Aug; 38(8):960-5.
    View in: PubMed
  212. Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ, Weber W, Jetton J, Kraus I, Pert J, Zallen B. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry. 1999 Aug; 38(8):966-75.
    View in: PubMed
  213. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999 Aug; 104(2):e20.
    View in: PubMed
  214. Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 1999 Jun; 19(3):257-64.
    View in: PubMed
  215. Cohen LG, Prince J, Biederman J, Wilens T, Faraone SV, Whitt S, Mick E, Spencer T, Meyer MC, Polisner D, Flood JG. Absence of effect of stimulants on the phamacokinetics of desipramine in children. Pharmacotherapy. 1999 Jun; 19(6):746-52.
    View in: PubMed
  216. Wilens TE, Biederman J, Millstein RB, Wozniak J, Hahesy AL, Spencer TJ. Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry. 1999 Jun; 38(6):680-5.
    View in: PubMed
  217. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, Spencer TJ, Wilens TE, Frazier J, Cleves M, Sakai J. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry. 1999 May; 156(5):768-70.
    View in: PubMed
  218. Wilens TE, Biederman J, March JS, Wolkow R, Fine CS, Millstein RB, Faraone SV, Geller D, Spencer TJ. Absence of cardiovascular adverse effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):573-7.
    View in: PubMed
  219. Wilens TE, Spencer TJ, Swanson JM, Connor DF, Cantwell D. Combining methylphenidate and clonidine: a clinically sound medication option. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):614-9; discussion 619-22.
    View in: PubMed
  220. Wilens T, Spencer T. Debate Forum: Clonidine plus methylphenidate is a clinically sound option; and In Response. J AM ACAD Child Adolesc Psychiatry. 1999; 257-264.
  221. Wilens T, Spencer T, Biederman J. Pharmacotherapy of adult attention deficit hyperactivity disorder. In: dunner D, Rosenbaum J, editors. Annual Review of Psychiatry. 1999; 18.
  222. Prince J, Wilens T, . Diagnosis and treatment of adults with ADHD. In: Accardo P, Blondis T, Whitman B, Stein M, editors. Attentiton Deficits and hypersctivity in children and adults. 1999; 665-682.
  223. Spencer TJ, Biederman J, Wilens T. Psychopharmacology of ADHD with antidepressants. In: Barkley R. ADHD: A Handbook for Diagnosis and Treatment. 1999.
  224. Biederman J, Mick E, Prince J, Bostic JQ, Wilens TE, Spencer T, Wozniak J, Faraone SV. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol. 1999; 9(4):247-56.
    View in: PubMed
  225. Bostic J, Wilen T, Spencer T, Biederman J. Treatment of depression in juveniles. International Journal of Psychiatry in Clinical Practice. 1999; 3:171-179.
  226. Spencer T, Biederman J, Wilens T. Treatment of Attention-deficit/hyperactivity disorder in adults. In: Greenhill L, Osman B, editors. Ritalin:Theory and Practice. 1999; 141-164.
  227. Bostic J, Wilens T, Biederman J, Spencer T. Pharmacological treatment of juvenile depression. In: Psychiatric Clinics of North America. 1999; 175-191.
  228. Cohen LG, Biederman J, Wilens TE, Spencer TJ, Mick E, Faraone SV, Prince J, Flood JG. Desipramine clearance in children and adolescents: absence of effect of development and gender. J Am Acad Child Adolesc Psychiatry. 1999 Jan; 38(1):79-85.
    View in: PubMed
  229. Wozniak J, Biederman J, Spencer T, Wilens T. Pediatric Psychopharmacology. In: Gelenberg A, Bassuk E, editors. The Practitioner's Guide to Psychoactive Substances. 1999; 385-416.
  230. Wilens T. Alcohol, drugs and ADHD. Alcohol and Research World. 1999; 22:127-130.
  231. Wilens T, McDermott S, Biederman J, Abrantes A, Hahesy A, Spencer T. Cognitive therapy for adults with ADHD: A systematic chart rebiew of 26 cases. Journal of Cognitive Psychotherapy. 1999; 13:215-226.
  232. T.E. Wilens. Straight Talk About Psychatric Medications for Kids. 1999.
  233. Wilens T, Biederman J, Spencer T. Attention-deficit/hyperactivity disorder in youth. In: Oldham JM, Riba M, editors. Annual Review of Psychiatry. 1999; 19.
  234. Wilens T. Pharmacotherapy for ADHD. Current Opinions in Central and Peripheral Nervous System Drugs. 1999; 453-465.
  235. Wilens TE, Wyatt D, Spencer TJ. Disentangling disinhibition. J Am Acad Child Adolesc Psychiatry. 1998 Nov; 37(11):1225-7.
    View in: PubMed
  236. Biederman J, Mick E, Bostic JQ, Prince J, Daly J, Wilens TE, Spencer T, Garcia-Jetton J, Russell R, Wozniak J, Faraone SV. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. J Clin Psychiatry. 1998 Nov; 59(11):628-37; quiz 638.
    View in: PubMed
  237. Daly JM, Wilens T. The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am. 1998 Oct; 45(5):1123-35.
    View in: PubMed
  238. Spencer T, Biederman J, Harding M, O'Donnell D, Wilens T, Faraone S, Coffey B, Geller D. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry. 1998 Oct; 39(7):1037-44.
    View in: PubMed
  239. Milberger S, Faraone SV, Biederman J, Chu MP, Wilens T. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders. Arch Pediatr Adolesc Med. 1998 Oct; 152(10):945-51.
    View in: PubMed
  240. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry. 1998 Aug 15; 44(4):269-73.
    View in: PubMed
  241. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics. 1998 Aug; 102(2 Pt 3):501-6.
    View in: PubMed
  242. O'Donnell D, Biederman J, Jones J, Wilens TE, Milberger S, Mick E, Faraone SV. Informativeness of child and parent reports on substance use disorders in a sample of ADHD probands, control probands, and their siblings. J Am Acad Child Adolesc Psychiatry. 1998 Jul; 37(7):752-8.
    View in: PubMed
  243. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1998 May; 155(5):693-5.
    View in: PubMed
  244. Wilens TE, Spencer TJ, Biederman J. Pharmacotherapy of ADHD in Adults. CNS Drugs. 1998; 9:347-356.
  245. Wilens T, Spencer T, Biederman J, Schleifer D. Attention-Deficit /hyperactivity disorder. In: Finberg L, editors. Saunders Manual of Pediatric Practice. 1998; 168-172.
  246. Wilens TE, Soencer TJ. Pharmacology of Amphetamines. In: Tarter RE, Ammerman RT, Ott PJ, editors. Handbook of Substance Abuse: Neurobehavioral Pharmacology. 1998; 501-513.
  247. Wilens T, Biederman J, Spencer T, . Pediatric Psychopharmacology. In: Koocher GP, Norcross JC, Hill S, editors. Psychologists Desk Reference. 1998; 404-412.
  248. Millberger S, Faraone S, Biederman J, Chu M, Wilens T. Familial risk analysis of the association between ADHD and PSUD. College of Problems and Drug Dependence, Scottsdale. 1998; 14:97.
  249. Wilens TE. AOD use and attention deficit/hyperactivity disorder. Alcohol Health Res World. 1998; 22(2):127-30.
    View in: PubMed
  250. Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry. 1998; 59 Suppl 7:59-68.
    View in: PubMed
  251. Wilens T, Spencer T, Biederman J. . Pharmacotherapy of ADHD in adults. In: Barkley R, editors. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 1998; 592-606.
  252. Biederman J, Spencer T, Wilens T. Attention -Deficit Hyperactivity Disorder. In: Stern T, Herman J, Slavin P, editors. MGH Practical Guide to Psychiatry for Primary Care Physicians. 1998; 445-454.
  253. Wilens T, Spencer T, Frazier J, Biederman J. Psychopharmacology in children and adolescents. In: Ollendick T, Hersen M, editors. Handbook of Child Psychopathology. 1998; 603-636.
  254. Solhkhah R, Wilens TE. Pharmacotherapy of adolescent alcohol and other drug use disorders. Alcohol Health Res World. 1998; 22(2):122-5.
    View in: PubMed
  255. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998; 7(2):156-63.
    View in: PubMed
  256. Biederman J, Wilens T, Mick E, Spencer T. Does ADHD impact remission from substance abuse. College of Problems and Drug Dependence, Scottsdale. 1998; 14:10.
  257. Bostic JQ, Wilens T, Spencer T, Biederman J. Juvenile mood disorders and office psychopharmacology. Pediatr Clin North Am. 1997 Dec; 44(6):1487-503.
    View in: PubMed
  258. Wilens TE, Spencer TJ, Biederman J. Sudden (un)explained death. J Am Acad Child Adolesc Psychiatry. 1997 Nov; 36(11):1487-8.
    View in: PubMed
  259. Bostic JQ, Wilens TE. How Should Pediatricians Approach the Depressed Adolescent? Adolesc Med. 1997 Oct; 8(3):517-526.
    View in: PubMed
  260. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997 Aug; 185(8):475-82.
    View in: PubMed
  261. Wilens TE, Biederman J, Abrantes AM, Spencer TJ. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. J Am Acad Child Adolesc Psychiatry. 1997 Jul; 36(7):941-7.
    View in: PubMed
  262. Bemporad J, Prince JB, Wilens TE. ADD: the media as a referral source. Harv Rev Psychiatry. 1997 Jul-Aug; 5(2):82-90.
    View in: PubMed
  263. Wilens TE, Spencer TJ, Biederman J, Schleifer D. Case study: nefazodone for juvenile mood disorders. J Am Acad Child Adolesc Psychiatry. 1997 Apr; 36(4):481-5.
    View in: PubMed
  264. Wilens T, Biederman J, Bredin E, Abrantes A, Schleifer D, Spencer T. . Psychopathology in the children of parents with opioid dependence. Scientific proceedings of the National Methadone Conference, Chicago. 1997.
  265. Biederman J, Faraone SV, Baldessarini RJ, Flood J, Meyer M, Wilens T, Spencer T, Chen L, Weber W. Predicting desipramine levels in children and adolescents: a naturalistic clinical study. J Am Acad Child Adolesc Psychiatry. 1997 Mar; 36(3):384-9.
    View in: PubMed
  266. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associated with early onset substance abuse. Scientific proceedings of the National Methadone Conference, Chicago. 1997.
  267. Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997 Jan; 36(1):45-8.
    View in: PubMed
  268. Milberger S, Biederman J, Faraone SV, Wilens T, Chu MP. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict. 1997; 6(4):318-29.
    View in: PubMed
  269. Biederman J, Spencer T, Wilens T. Psychopharmacology in children and adolescents. In: Nelson C, editors. Handbook of Pediatrics. 1997.
  270. Bostic J, Wilens T, Biederman J, Spencer T. Childhood mood disorders and office psychopharmacology. In: Brown R, editors. Pediatric Clinics of North America. 1997; (44):1487-1504.
  271. Millstein R, Wilens T, Biederman J, Spencer T. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. Journal of Attention Disorders. 1997; 2:159-165.
  272. Biederman J, Spencer T, Wilens T. Pediatric Psychopharmacology. In: Weiner J, editors. Textbook of Child and Adolescent Psychiatry. 1997; 779-812.
  273. Spencer T, Biederman J, O'Donnell D, Harding M, Wilens T, Coffey B, Geller D. Desipramine in ADHD and tic disorder or Tourette's syndrome. 44th Annual Meetings of the American Academy of Child and Adolescent Psychiatry, Toronto. 1997; 13:102.
  274. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1997 Jan; 36(1):21-9.
    View in: PubMed
  275. Frazier J, Spencer T, Wilens T, Wozniak J Biederman J. Childhood-onset schizophrenia as the prototypic psychotic disorder of childhood. In: Psychiatric Clinics of North America: Annual of Drug Therapy. 1997; 167-193.
  276. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associted with early onset and specific pathways of substance abuse. College of Problems with Drug Dependence, Nashville. 1997.
  277. Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder: A lifespan perspective. In: Dickstein L, Riba M, Oldham J, McElroy S, editors. Review of Psychiatry. 1997; 16(IV):87-128.
  278. Spencer T, Biederman J, Harding M, O'Donnell D, Faraone S, Wilens T. Growth deficits in ADHD revisited: Evidence for growth delay. 44th Annual Meetings of the American Academy of Child and Adolescent Psychiatry, Toronto. 1997; 13:155.
  279. Wozniak J, Biederman J, Spencer T. Pediatric Psychopharmacology. In: Gelenberg A, Bassuk E, editors. The Practitioner's Guide to PSychactive Substances. 1997; 385-415.
  280. Wilens T, Biederman J, Spencer T. Pharmacotherapy of Adult AD/HD. In: ADD in Adults: Strategies for Success from C.H.A.D.D. 1997; 35-40.
  281. Wilens T, Biederman J, Spencer T. Psychopharmacology for children and adolescents. In: Cassem N, editors. MGH Handbook of General Hospital Psychiatry. 1997; 467-486.
  282. Wilens T, Spencer T, Prince J, Frazier, Millstein R, Hatch M, Soriano J, Sienna M, Biederman J. A double blind comparison of pemoline and placebo for adolescents with ADHD. 44th Annual Meetings of the American Academy of Child and Adolescent Psychiatry, Toronto. 1997; 13:107.
  283. Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ, Birmaher B, Goldblatt A. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1996 Nov; 35(11):1491-501.
    View in: PubMed
  284. Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry. 1996 Nov; 35(11):1460-9.
    View in: PubMed
  285. Wilens TE, Biederman J, Abrantes AM, Spencer TJ. A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1996 Nov; 35(11):1485-90.
    View in: PubMed
  286. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996 Sep; 153(9):1147-53.
    View in: PubMed
  287. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry. 1996 May; 53(5):437-46.
    View in: PubMed
  288. Prince JB, Wilens TE, Biederman J, Spencer TJ, Wozniak JR. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996 May; 35(5):599-605.
    View in: PubMed
  289. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996 Apr; 35(4):409-32.
    View in: PubMed
  290. Biederman J, Wilens T, Mick E, Farone S, Weber W, Curtis S, Thornell A, Pfister K, Jetton G, Soriano J. Psychoactive substance use disorders: Is ADHD a risk factor?. American Academy of Child and Adolescent Psychiatry, Philadelphia. 1996; 12(103).
  291. Wilens T, Biederman J, Abrantes A, Spencer T. Effect of psychopharmacological treatment in substance abusing youth. American Academy of Addiction Psychiatry, San Francisco. 1996; 7:9.
  292. Wilens T, Biederman J, Spencer T. Attention deficit hyperactivity disorder and the Psychoactive substance use disorders. In: Jaffee S, editors. Pediatric Substance Use Disorders" Child and Adolescent Psychiatric Clinics of North America. 1996; 5(1):73-91.
  293. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associated with early onset substance abuse. NIDA Research Monograph. 1996; 220.
  294. Wilens T, Biederman J, Abrantes A, Spencer T. Characterisitics of substance abusing youth in an outpatient pediatric Psychopharmacology clinic. American Academy of Child and Adolescent Psychiatry, Philadelphia. 1996; 12:102.
  295. Biederman J, Wilens T, Mick E, Faraone S, Weber W, Curtis S, Thornell A, Pfister K, Jetton G, Soriano J. Psychoactive substance use disorders: Is ADHD a risk factor?. American Academy of Child and Adolescent Psychiatry, Philadelphia. 1996; 12:103.
  296. Biederman J, Spencer T, Wilens T . ADHD: Pharmacotherapy. In: Gabbard G, Atkinson S, editors. Synopsis of Tretments of Psychiatric Disorders. 1996.
  297. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associated with early onset substance abuse. Scientific proceedings of the College on Problems of Drug Dependence, Puerto Rico. 1996; 58:150.
  298. Biederman J, Wilens TE, Spencer TJ, Faraone S, Mick E, Ablon JS, Kiely K. Diagnosis and treatment of adults with attention deficit hyperactivity disorder (ADHD). In: Pollack M, Otto M, Rosenbaum J, editors. Challenges in Clinical Practice : Pharmacologic and Psychosocial Strategies. 1996; 380-407.
  299. Daly J, Biederman J, Prince J, Wilens T, Soriano J, Russel R. The effects of psychopathology and nortriptyline on automatic control of the heart. American Academy of Child and Adolescent Psychiatry, Philadelphia. 1996; 12:130.
  300. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associated with early onset substance abuse. American Academy of Child and Adolecent Psychiatry, Philadelphia. 1996; 12:96.
  301. Wilens T, Biederman J, Mick E, Faraone S, Spencer T. ADHD is associated with early onset substance abuse. Scientific proceedings of the American Academy of Addiction Psychiatry, San Francisco. 1996; 7:9.
  302. Spencer T, Biederman J, O'Donnell D, Hatch M, Wilens T. ADHD-specific dysfunction in tic disordered children. American Academy of Child and Adolescent Psychiatry, Philadelphia. 1996; 12:99.
  303. Wilens T, Spencer T, Biederman J, Linehan C. Child and Adolescent Psychopharmacology. In: Michels R, editors. Psychiatry. 1996; 2(69):1-26.
  304. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995 Nov; 152(11):1652-8.
    View in: PubMed
  305. Spencer T, Biederman J, Harding M, Wilens T, Faraone S. The relationship between tic disorders and Tourette's syndrome revisited. J Am Acad Child Adolesc Psychiatry. 1995 Sep; 34(9):1133-9.
    View in: PubMed
  306. Wilens TE, Spencer TJ, Biederman J. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related? Harv Rev Psychiatry. 1995 Sep-Oct; 3(3):160-2.
    View in: PubMed
  307. Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol. 1995 Aug; 15(4):270-9.
    View in: PubMed
  308. Wilens TE, Prince JB, Biederman J, Spencer TJ, Frances RJ. Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults. Psychiatr Serv. 1995 Aug; 46(8):761-3, 765.
    View in: PubMed
  309. Wilens TE, Biederman J, Spencer TJ. Venlafaxine for adult ADHD. Am J Psychiatry. 1995 Jul; 152(7):1099-100.
    View in: PubMed
  310. Spencer T, Biederman J, Wilens T, Guite J, Harding M. ADHD and thyroid abnormalities: a research note. J Child Psychol Psychiatry. 1995 Jul; 36(5):879-85.
    View in: PubMed
  311. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995 Jun; 52(6):434-43.
    View in: PubMed
  312. Wilens TE, Biederman J, Kiely K, Bredin E, Spencer TJ. Pilot study of behavioral and emotional disturbances in the high-risk children of parents with opioid dependence. J Am Acad Child Adolesc Psychiatry. 1995 Jun; 34(6):779-85.
    View in: PubMed
  313. Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry. 1995 Mar; 152(3):431-5.
    View in: PubMed
  314. Wilens T, Prince J, Biederman J, Spencer T, Linehan C, Warburton R, Schleifer D, Moore P, Geller D. Double blind comparison of desipramine and placebo in adults with attention deficit hyperactivity disorder. Scientific proceedings of the American Psychiatric Association, Miami. 1995; 148:227.
  315. Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1995 Jan; 34(1):36-44.
    View in: PubMed
  316. Spencer T, Biederman J, Wilens T, Prince J. Effectiveness and tolerability of Tomoxetine in adults with ADHD. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:109.
  317. Wilens TE, Biederman J, Mick E, Spencer TJ. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis. 1995 Jan; 183(1):48-50.
    View in: PubMed
  318. Spencer T, Biederman J, Wilens T, Faraone S. Importance of ADHD in tic associated psychopathology and dydfunction. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:109.
  319. Prince J, Wilens T, Biederman J, Spencer T. A naturalistic study of the coadministration of psychostimulants and desipramine; Effects on serum desipramine levels. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:124.
  320. Wilens T, Spencer T, Biederman J. Pharmacotherapy of adult ADHD. In: Nadeau KG, editors. A Comprehensive Guide to Attention Deficit Disorder in Adults. 1995; 168-188.
  321. Wilens TE, Spencer T, Biederman J, Wozniak J, Connor D. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 1995 Jan; 34(1):110-2.
    View in: PubMed
  322. Wilens T, Prince J, Biederman J, Spencer T, Linehan C, Warburton R, Schleifer D, Moore P, Geller D. Double blind comparison of desipramine and placebo in adults with attention deficit hyperactivity disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:125.
  323. Wilens T, Biederman J, Mick E, Faraone SV. Alcohol and drug use disorder in adults with attention deficit hyperactivity disorder: Effect of comorbidity. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:112.
  324. Wilens T, Biederman J, Mick E, Faraone SV. Alcohol and drug use disorder in adults with attention deficit hyperactivity disorder: Effect of comorbidity. Scientific proceedings of the American Psychiatric Association, Miami. 1995; 148:227.
  325. Biederman J, Spencer T, Wilens T, Sprich-Buckminster S. . ADHD: Pharmacotherapy. In: Gabbard GA, Editors. Treatments of Psychiatric Disorders. 1995; 167-188.
  326. Spencer T, Biederman J, FaraoneS, Wilens T. Growth deficits in ADHD revisted: Evidence for growth delay. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:109.
  327. Spencer T, Wilens T, Biederman J. Psychotropic medication for children . In: Riddle M, editors. Child and Adolescent Clinics of North America. 1995; 97-122.
  328. Wilens T, Biederman J, Baldessarini RJ, Geller B, Spencer T, Birmaher B, Schleifer D. The cardiovascular effects of tricyclic antidepressants in children and adolescents. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New Orleans. 1995; 11:125.
  329. Spencer T, Biederman J, Wilens T. Tricyclic antidepressant treatment of children with ADHD and tic disorders. J Am Acad Child Adolesc Psychiatry. 1994 Oct; 33(8):1203-4.
    View in: PubMed
  330. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994 Jul; 53(1):13-29.
    View in: PubMed
  331. Wilens TE, Biederman J, Spencer TJ, Frances RJ. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Hosp Community Psychiatry. 1994 May; 45(5):421-3, 435.
    View in: PubMed
  332. Wilens TE, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1994 Mar-Apr; 33(3):424-6.
    View in: PubMed
  333. Spencer T, Biederman J, Wilens T, Faraone SV. Is attention-deficit hyperactivity disorder in adults a valid disorder? Harv Rev Psychiatry. 1994 Mar-Apr; 1(6):326-35.
    View in: PubMed
  334. Wilens TE, Saley P, Renner JA, O'Keefe J. A public dual diagnosis detoxification unit: III. Efficacy of treatment. American Journal of Addictions. 1994; 3:194-203.
  335. Biederman J, Farone S, Mick E, Spencer T, Wilens T. Risk for ADHD in children of parents with childhood onset ADHD. Scientific proceedings of the American Academy of Child and Adolescent Psychiatrists, New York. 1994; 1:65.
  336. Geller DA, Biederman J, Reed E, Spencer T, Wilens T, Griffin S, Lelon E. Fluoxetine in pre and postpubertal obsessive compulsive disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatrists, New York. 1994; 10:56.
  337. Wilens T, Prince J, Spencer T, Geller D, Warburton R, Moore P, Biederman J. Double blind comparison of desipramine and placebo in adults with attention deficit hyperactivity disorder: Preliminary results. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New York. 1994; 10:42.
  338. Prince J, Wilens T, Spencer T, Wozniak J, Biederman J. Clonidine for ADHD related sleep disturbances. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New York. 1994; 10:45.
  339. Wilens TE. Child and adolescent offspring of drug and alcohol dependent parents. Current Opinions in Psychiatry. 1994; 7(4):319-232.
  340. Biederman J, Faraone S, Spencer T, Wilens T, Mick E, Lapey K. Gender differences in a sample of adults with ADHD. NCDEU, Marco Island Fl. 1994.
  341. Spencer T, Biederman J, Wilens T, Guite J. Attention deficit hyperactivity disorder and thyroid abnormalities. Scientific proceedings of the Amercian Academy of Child and Adolescent Psychiatry. 1994; 33:919.
  342. Spencer T, Wilens T, Biederman J, Faraone S, Ablon S, Lapey K. A double blind comparison of methlphenidate and placebo in adults with attention deficit hyperactivity disorder. 34th annual meeting of the New Clinical Drug Evaluation Unti Program, Marco Island. 1994.
  343. Spencer T, Biederman J, Harding M, Wilens T, Faraone SV. Patterns of psychiatric comorbidity and cognition in children with tic disorders. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New York. 1994; 10:58.
  344. Biederman J, Faraone S, Spencer T, Wilens T. Mick E, Lapey K. Gender differences in adults with attention deficit hyperactivity disorder. 34th annual meeting of the New Clinical Drug Evaluation Unit Program, Marco Island. 1994.
  345. Spencer TJ, Wilens TE, Biederman J. Tricyclic antidepressant treatment of hypersctivity. Current Opinions in Psychiatry. 1994; 7(4):304-307.
  346. Wilens T, Biederman J, Bredin E, Kiely K, Spencer T. . A pilot study of behavioral and emotional disturbances in the children of opioid dependent parents. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New York. 1994; 10:82.
  347. Wilens T, Biederman J, Mick E, Faraone SV. Alcohol and drug use disorder in adults with attention deficit hyperactivity disorder: Effect of comorbidity. Fifth annual proceedings of the American Academy of Psychiatrists in Alcoholism and Addictions, San Diego. 1994.
  348. Wilens TE, Kiely K, Bredin E, Spencer T, Biederman J. . Behavorial and emotional disturbances in children of parents with opioid dependence. Fourth annual proceedings of the American Academy of Psychiatrists in Alcoholism and Addictions, San Diego. 1993; 24.
  349. Wilens T, Biederman J, Spencer T, Norman D, Lapey K, Mick E, Lehman B, Doyle A. Rates of alcohol and drug use disorders in adults with ADHD. Fourth annual proceedings of the American Academy of Psychiatrists in Alcoholism and Addictions, San Diego. 1993.
  350. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993 Dec; 150(12):1792-8.
    View in: PubMed
  351. Wilens TE, Saley P, Renner JA, O'Keefe J. A Public Dual Diagnosis Detoxification Unit: Short-Term Efficacy of Treatment. Fourth annual proceedings of the American Academy of Psychiatrists in Alcoholism and Addictions, San Diego. 1993.
  352. Wilens TE, Biederman J. Psychopathology in preadolescent children at high risk for substance abuse: a review of the literature. Harv Rev Psychiatry. 1993 Nov-Dec; 1(4):207-18.
    View in: PubMed
  353. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993 Jul; 32(4):798-804.
    View in: PubMed
  354. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 1993 Mar; 32(2):350-3.
    View in: PubMed
  355. Wilens TE, Biederman J, Spencer T, Geist DE. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1993 Mar; 32(2):270-7.
    View in: PubMed
  356. Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T. Nortriptyline in the treatment of ADHD: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry. 1993 Mar; 32(2):343-9.
    View in: PubMed
  357. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1993 Mar; 32(2):354-60.
    View in: PubMed
  358. Wilens T, Biederman J, Mick E, Spencer T. Treatment of adult ADHD with tricyclic antidepressants: Clinical experience with 32 patients. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, San Antonio. 1993; 9.
  359. Spencer T, Biederman J, Steingard R, Wilens T. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1993 Jan; 32(1):211-4.
    View in: PubMed
  360. Renshaw PF, Biederman J, Wilens T, Spencer T, Cohen B. MRI abnormalities in children with ADHD. Biol Psych. 1993; 32.
  361. Wilens T, Herzog L, Renner J. . Use of clonazepam for alprazolam withdrawal: Clinical observations of six methadone-maintained cases. American Journal on Addictions. 1993; 2(4):325-329.
  362. Wilens TE, O'Keefe J, O'Connell JJ, Springer R, Renner J. A Public dual diagnosis detoxification unit: I. Organization and structure. American Journal on Addictions. 1993; 2(2):1-8.
  363. Spencer T, Wilens T, Biederman J, Faraone S, Ablon S, Lapey K. A double blind comparison of methylphenidate and placebo in adults with ADHD. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, San Antonio. 1993; 9:42.
  364. Spencer T, Biederman J, Wilens T, Steingard R, Geist D. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1993 Jan; 32(1):205-10.
    View in: PubMed
  365. Biederman J, Faraone S, Spencer T, Wilens T, Mick E, Lapey K. Gender differences in a sample of adults with ADHD. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, San Antonio. 1993; 9:43.
  366. Wilens TE, O'Keefe J, O'Connell J, Springer R, Spencer TJ. A public dual diagnosis detoxification unit: II. Observations of 70 dually disgnosed patients. American Journal on Addictions. 1993; 2(3):1-13.
  367. Wilens TE, Biederman J, Baldessarini RJ, McDermott SP, Puopolo PR, Flood JG. Fluoxetine inhibits desipramine metabolism. Arch Gen Psychiatry. 1992 Sep; 49(9):752.
    View in: PubMed
  368. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG. Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):691-8.
    View in: PubMed
  369. Wilens TE, Biederman J. The stimulants. Psychiatr Clin North Am. 1992 Mar; 15(1):191-222.
    View in: PubMed
  370. Spencer T, Biederman J, Wilens T, Lapey K. Methylphenidate treatment in adults with childhood onset attention-deficit hyperactivity disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington D.C. 1992; 8:74.
  371. Wilens TE, Steingard R, Biederman J. Clomipramine for comorbid conditions. J Am Acad Child Adolesc Psychiatry. 1992 Jan; 31(1):171.
    View in: PubMed
  372. Spencer T, Biederman J, Wilens T, SteingardR, Geist D. Nortriptyline treatment of attention-deficit hyperactivity disorder and tic disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington D.C. 1992; 8:74.
  373. Wilens TE, Biederman J, Baldessarini RJ, Puopolo P, Flood J. Developmental changes in serum concentrations of desipramine and 2- hydroxydesipramine during treatment with desipramine. Biol Psych. 1992; 31(5A):242.
  374. Spencer T, Biederman J, Steingard, R, Wilens T. Bupropion exacerbates tics in children with attention deficit disorder and Tourette's disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington D.C. 1992; 8:53.
  375. Wilens TE, Biederman J, Spencer T, Steingard R, Geist D. . Nortriptyline in children and adolescents: ADHD response serum levels, and EKG effects. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington DC. 1992; 8:75.
  376. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. Clonidine response in the treatment of ADHD with and without comorbid tic disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington D.C. 1992; 8.
  377. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T. Desipramine treatment of attention-deficit hyperactivity disorder and tic disorder. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry. Washington D.C. 1992; 8:74.
  378. Wilens TE, Biederman J. The Stimulants. In: Shaffer D, Editors. The Psychiatric Clinics of North America. 1992; 191-222.
  379. Wilens TE, Biederman J, Baldessarini RJ, Puopolo P, Flood J. The developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine in children, adolescents, and adults. Scientific preoceedings of the American Academy of Child and Adolescent Psychiatry, San Francisco. 1991; 7:58.
  380. Wilens TE, Stern TA, O'Gara PT. Adverse cardiac effects of combined neuroleptic ingestion and tricyclic antidepressant overdose. J Clin Psychopharmacol. 1990 Feb; 10(1):51-4.
    View in: PubMed
  381. Wilens TE, Stern TA. Ventricular tachycardia associated with desipramine and thioridazine. Psychosomatics. 1990; 31(1):100-3.
    View in: PubMed
  382. Zamvil L, Wilens TE, Levy J. The endocrine system and sexually related disorders. In: Wesson D, Rahdert E, Editors. Treatment Manual: Medical Complication of Drug Abuse. Bethesda: National Institute of Drug Abuse Manuscript. 1990.
  383. Wilens TE. Depression in the medically ill child. In: Jellinek MS, Herzog DB, editors. The Massachusetts General Hospital Handbook of Psychiatric Aspects of General Hospital Pediatrics. 1990; 263-271.
  384. Stoddard F, Wilens TE. Delirium. in: Jellinek MS, Herzog DB, editors. The Massachusetts General Hospital Handbook of Psychiatric Aspects of General Hospital Pediatrics. 1990; 254-259.
  385. Arana GW, Wilens TE, Baldessarini RJ. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients. Psychoneuroendocrinology. 1985; 10(1):49-60.
    View in: PubMed
  386. Wilens TE, Ritchie JC, Carroll BJ. Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia. Psychoneuroendocrinology. 1984; 9(1):45-55.
    View in: PubMed
  387. Sellinger OZ, Schatz RA, Porta R, Wilens TE. Brain methylation and epileptogenesis: the case of methionine sulfoximine. Ann Neurol. 1984; 16 Suppl:S115-20.
    View in: PubMed
  388. Arana GW, Barreira PJ, Wilens TE, Baldessarini RJ, Cohen BJ, Lipinski JF. Clinical studies of the dexamethasone suppression test in psychotic illness. Psychopharm Bull. 1984; 19(3).
  389. Wilens TE, Arana GW, Baldessarini RJ, Cremens C. Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients. Psychiatry Res. 1983 Mar; 8(3):199-206.
    View in: PubMed
  390. Schatz RA, Wilens TE, Tatter SB, Gregor P, Sellinger OZ. Possible role of increased brain methylation in methionine sulfoximine epileptogenesis: effects of administration of adenosine and homocysteine thiolactone. J Neurosci Res. 1983; 10(4):437-47.
    View in: PubMed
  391. Wilens TE, Arana GW, Baldessarini RJ. Comparison of solid-phase radioimmunoassay and a competitive protein binding method for post-dexamethasone cortisol levels in psychiatric patients. Clin Res. 1983; 31(4):818.
  392. Arana GW, Wilens TE, Baldessarini RJ. Clinical studies in the dexamethasone supression test in severe psychiatric illnesses. Proceedings of the Society of Biological Psychiatry. 1983.
  393. Palella TD, Schatz RA, Wilens TE, Fox IH. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes. J Lab Clin Med. 1982 Aug; 100(2):269-78.
    View in: PubMed
  394. Schatz RA, Wilens TE, Tatter SB, Sellinger OZ. Hypermethylation in the MSO-epileptogenic brain. Reversal by dilantn, phenobarbital, or adenosine plus homocysteine. The Toxicologist. 1982; 2:2.
  395. Wilens TE, Ritchie JC, Carroll BJ. Comparison of plasma cortisol (F) and corticosterone (B) in the dexamethasone suppression test. Clin Res. 1982; 30(4):832.
  396. Wilens TE, Biederman J, Baldessarini RJ, Puopolo P, Flood J. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents , and adults treated with desipramine. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, Washington D.C. 1982; 8:70.
  397. Wilens TE, Schatz RA, Sellinger OZ. Inhibition of transmethylation reactions by in vivo elevation of cerebral S-adenosylhomocysteine levels: A potential mchanism of anticonvulsant action. Clin Res. 1982; 30(4):823.
  398. Schatz RA, Wilens TE, Tatter SB, Sellinger OZ. Hypermethylation in the methionine sulfoximine opileptogenic brain: Reversal by dialntin or phenobarbital. In: Borchardt T, Usdin E, Creveling CR, editors.The Biochemistry of S-Adenosylmethionine and Related Compounds. 1982; 675-678.
  399. Porta R, Doyle RL, Tatter SB, Wilens TE, Schatz RA, Sellinger OZ. The biosynthesis of polyamines in the brain of audiogenic seizure-susceptible and -resistant deermice. J Neurochem. 1981 Sep; 37(3):723-9.
    View in: PubMed
  400. Schatz RA, Wilens TE, Sellinger OZ. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-l-homocysteine. J Neurochem. 1981 May; 36(5):1739-48.
    View in: PubMed
  401. Turner BB, Wilens TE, Schroeder KA, Katz RJ, Carroll BJ. Comparison of brainstem and adrenal circadian patterns of epinephrine synthesis. Neuroendocrinology. 1981 May; 32(5):257-61.
    View in: PubMed
  402. Schatz RA, Wilens TE, Sellinger OZ. Decreased in vivo protein and phospholipid methylation after in vivo elevation of brain S-adenosyl-homocysteine. Biochem Biophys Res Commun. 1981 Feb 27; 98(4):1097-107.
    View in: PubMed
  403. Schatz RA, Wilens TE, Sellinger OZ. The elevation of brain S-adenosyl-homocysteine in vivo counteracts the MSO-induced increase in phospholipid and protein carboxymethylation. Tranactions of the Society of Neurochemistry. 1981; 12:163.
  404. Schatz R, Wilens TE, Sellinger OZ. Elevation of mouse brain S-adenosylhomocysteine in vivo: Effects on histamine and it;s catabolism. Transactions of the Society of Neurochemistry. 1980; 11:244.
  405. Schatz RA, Wilens TE, Doyle RL, Sellinger OZ. Studies on cerebral transmethylation. Federation Proceedings. 1980; 39:2141.
  406. Pallela TD, Schatz RA, Kaminska JB, Wilens TE, Fox IH. Homocysteine dependent nucleoside toxicity in cultured T- and B- lymphoblasts. Proceedings of the American Rheumatism Association. 1980; 28:488.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Wilens's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_